Equities

Yichang Hec Changjiang Pharmaceutical Co Ltd

Yichang Hec Changjiang Pharmaceutical Co Ltd

Actions
Health CarePharmaceuticals & Biotechnology
  • Price (HKD)24.35
  • Today's Change-0.150 / -0.61%
  • Shares traded438.20k
  • 1 Year change44.25%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2017 06:50 GMT.
More ▼

Events & Activity

  • 1558:HKG price moved over -1.20% to 24.65

Key statistics

As of last trade Yichang Hec Changjiang Pharmaceutical Co Ltd (1558:HKG) traded at 24.35, -5.44% below its 52-week high of 25.75, set on Nov 14, 2017.
52-week range
Today
13.82Dec 16 201625.75Nov 14 2017
Markit short selling activity
Low
Med
High
Open24.60
High24.70
Low24.25
Bid24.35
Offer24.40
Previous close24.50
Average volume772.97k
Shares outstanding452.02m
Free float124.55m
P/E (TTM)20.08
Market cap11.07bn HKD
EPS (TTM)1.22
HKD
Annual div (ADY)0.6498
HKD
Annual div yield (ADY)2.66%
Div ex-dateOct 17 2017
Div pay-dateNov 10 2017
Data delayed at least 15 minutes, as of Nov 22 2017 06:50 GMT.
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.